Allianz Asset Management
IMMU

Allianz Asset Management’s Immunomedics Inc IMMU Stock Holding History

Allianz Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,300
Closed -$366K – 2010
2020
Q3 		$366K Buy
+4,300
New +$217K ﹤0.01% 1670

Allianz Asset Management's IMMU Position: Q4 2020 in Review

Allianz Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,153,818 shares — an estimated $98.1M sold.

Allianz Asset Management first reported a position in IMMU in Q2 2013 and held it in 20 quarters. The position peaked at $98.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Allianz Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Allianz Asset Management sold 1,153,818 Immunomedics Inc shares in Q4 2020, an estimated $98.1M.
  • Allianz Asset Management first reported a position in Immunomedics Inc in Q2 2013 and held it in 20 quarters.
  • Allianz Asset Management's Immunomedics Inc position peaked at $98.1M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Allianz Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.